Summer Haven Investment Management, LLC Catalyst Pharmaceuticals, Inc. Transaction History

Summer Haven Investment Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 24, 2023	SELL	$11.5 - $18.08 $85,514 - $134,442	-7,436 Reduced 7.39%	93,156 $1.25 Million
Q1 2023 Apr 13, 2023	BUY	$14.34 - $21.05 $14,755 - $21,660	1,029 Added 1.03%	100,592 $1.67 Million
Q4 2022 Jan 18, 2023	BUY	$12.25 - $19.5 $8,856 - $14,098	723 Added 0.73%	99,563 $0
Q3 2022 Oct 20, 2022	SELL	$7.06 - $15.52 $421,008 - $925,504	-59,633 Reduced 37.63%	98,840 $1.27 Million
Q1 2022 May 04, 2022	BUY	$5.31 - $8.31 $37,642 - $58,909	7,089 Added 4.68%	158,473 $1.31 Million
Q3 2021 Oct 20, 2021	BUY	$4.85 - $6.04 $734,212 - $914,359	151,384 New	151,384 $802,000

327

94.1M

19.1K

51.1K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.33B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Summer Haven Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Summer Haven Investment Management, LLC with notifications on news.